FAM111B as a Key Driver and Therapeutic Target in Glioma Progression

FAM111B, a DNA-repair protein, drives glioma progression by activating the PI3K/AKT pathway. Overexpression promotes tumor growth, invasion, and worsens prognosis. Targeting FAM111B offers a promising new therapeutic approach for glioma treatment.